Mimix Reference Standards for Monitoring Oncology Diagnostic Testing Workflows Introduced
Revvity has launched three FDA-compliant Mimix reference standards for IVD use, aimed at enhancing NGS and ddPCR assays.
Revvity has launched three FDA-compliant Mimix reference standards for IVD use, aimed at enhancing NGS and ddPCR assays.
A recent court ruling excluding LDTs from FDA regulation highlights the urgent need for the diagnostics industry to modernize oversight.
AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.
Festo's SupraMotion uses superconducting technology to enable automated, contactless handling across sterile and non-sterile environments.
Labcorp has expanded its precision oncology portfolio with new tests for solid tumors and blood cancers to support diagnostic development.